Tetrazine-Mediated Bioorthogonally Activated Therapeutic (TBAT) Platforms
Journal of the American Chemical Society · 11.03.2026 · 148 (9) · 9169-9184
DOI: 10.1021/jacs.5c23084 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Chemical Society, online erschienen am 02.03.2026. Verfasst von Jungryun Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Korea University, Seoul 02841, Korea. Hauptthemen laut MEDLINE: Heterocyclic Compounds, 1-Ring. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Korea University, Seoul 02841, Korea.
- National Research Laboratory for Convergence Degradation Biology, Korea University, Seoul 02841, Korea.
ORCID-Profile: Snehasish Debnath, Jong Seung Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, J., Debnath, S., Kim, E., Yoon, C., Seo, J., Hua, S., & Kim, J. S. (2026). Tetrazine-Mediated Bioorthogonally Activated Therapeutic (TBAT) Platforms. Journal of the American Chemical Society, 148(9), 9169-9184. https://doi.org/10.1021/jacs.5c23084
Vancouver
Kim J, Debnath S, Kim E, Yoon C, Seo J, Hua S, et al. Tetrazine-Mediated Bioorthogonally Activated Therapeutic (TBAT) Platforms. Journal of the American Chemical Society. 2026;148(9):9169-9184. doi:10.1021/jacs.5c23084
BibTeX
@article{Kim2026,
author = {Kim, Jungryun and Debnath, Snehasish and Kim, Eunji and Yoon, Changyu and Seo, Jiwoo and Hua, Siwei and Kim, Jong Seung},
title = {Tetrazine-Mediated Bioorthogonally Activated Therapeutic (TBAT) Platforms},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {9},
pages = {9169--9184},
doi = {10.1021/jacs.5c23084}
}
EUVIMED